The International Journal of Biochemistry & Cell Biology
- Print ISSN
- Electronic ISSN
- Impact factor
- Usage rank
- Article count
- Free count
- Free percentage
- PDFs via platforms
- Sciencedirect from 1995, Rcgp, Gale, CSA, Proquest, and Ingenta
Oncogenic Human Papillomavirus 16E7 modulates SUMOylation of FoxM1b.
We report that FoxM1b interacts with SUMOylating enzymes Ubc9 and PIAS1 and acts as a substrate for SUMOylation. We also show that SUMOylation facilitates FoxM1b protein destabilization and nucleocytoplasmic shuttling. More importantly, we provide the first evidence for a role of E7 oncoprotein in h...
A splice variant of the human phosphohistidine phosphatase 1 (PHPT1) is degraded by the proteasome.
Regulation of protein activity by phosphorylation is central in many cellular processes. Phosphorylation of serine, threonine and tyrosine residues is well documented and studied. In addition, other amino acids, like histidine can be phosphorylated, but neither the mechanism nor the function of this...
Transient receptor potential vanilloid 1 is expressed in human cytotrophoblasts: Induction of cell apoptosis and impairment of syncytializat...
We found that TRPV1 is expressed in human cytotrophoblasts and syncytiotrophoblasts. Furthermore, the TRPV1 agonists capsaicin and anandamide decreased cytotrophoblast viability and induced morphological alterations, such as chromatin condensation and fragmentation, which suggest the occurrence of a...
MicroRNAs in development and disease
Erratum to: Impairment of IGF-I gene splicing and MGF expression associated with muscle wasting
Editorial board / Publication Information
Structure and functional evaluation of porcine NANOG that is a single-exon gene and has two pseudogenes.
We report, for the first time, that porcine NANOG is encoded by a single exon gene (SEG) mapped on chromosome 1 and has two daughter genes, one pseudogene NANOGP1 on chromosome 5 and one tandem duplicate on chromosome 1. The duplicated pseudogene NANOGP2 has high sequence similarity to NANOG, but do...